Previous 10 | Next 10 |
LEXINGTON, Mass., June 17, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies and cancer vaccines, announced today that Dr. J...
LEXINGTON, Mass. , June 16, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infectious diseases, announces that it will host its 2020 Annual Shareholders Meeting virtually ...
Agenus (NASDAQ: AGEN) , a small-cap immunotherapy company, saw its stock gain a healthy 51% during the month of May, according to data from S&P Global Market Intelligence . The biotech's shares perked up late last month in response to a positive clinical update for its cancer immuno...
Celyad Reports Positive Update on Non Gene Edited Allogeneic CAR-T Therapy Celyad ( CYAD ) announced update for its Phase 1 clinical trial alloSHRINK. The trial aims to assess the potential of its lead drug candidate CYAD-101 for patients suffering from metastatic colorectal cancer. It e...
Westwater Resources (NASDAQ: WWR ) +144% on positive independent test results on ULTRA-PMG. More news on: Westwater Resources, Inc., Tenax Therapeutics, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...
The FDA has cleared Agenus (NASDAQ: AGEN ) unit, AgenTus Therapeutics' IND application for an allogeneic iNKT therapy, as a potential therapy for treatment of patients with COVID-19. More news on: Agenus Inc., Healthcare stocks news, Stocks on the move, Read more ...
LEXINGTON, Mass. , June 2, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infectious diseases, announced today the FDA's clearance of AgenTus' IND application for an ...
3 Penny Stocks To Watch Right Now Putting your money into penny stocks can be exciting and scary at the same time. Exciting because penny stocks offer high potential for large gains. Scary because these high flying penny stocks are also highly risky too. But if you can handle a little bit of...
Shares of Agenus (NASDAQ: AGEN) jumped over 23% today after the company announced a presentation at the American Society of Clinical Oncology (ASCO) meeting discussing the progress of AGEN1181 in solid-tumor cancers. The drug candidate delivered clinical benefit in 70% of patients wit...
Gainers: Sonoma Pharmaceuticals (NASDAQ: SNOA ) +145% . More news on: Sonoma Pharmaceuticals, Inc., Adaptimmune Therapeutics plc, Phio Pharmaceuticals Corp., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its second quarter 2024 financial results before the market opens on Thursday, August 8, 2024. Agenus executives will host a co...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
2024-07-18 12:11:22 ET Agenus Inc (NASDAQ: AGEN) faced a dramatic decline in its stock price on Thursday, plummeting more than 50%, following the US Food and Drug Administration (FDA’s) decision to advise against pursuing accelerated approval for its BOT/BAL colorectal cance...